Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 11,972 shares at $27.84 ($334K) on 2018-06-19, disclosed to the SEC on 2018-06-20.
Open-market sale of $334k NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.84 | 5,286 | $147K | 44.1% |
| 2 | $27.84 | 5,286 | $147K | 44.1% |
| 3 | $28.39 | 1,400 | $40K | 11.9% |
| Total | $27.90 avg | 11,972 | $334K | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |